Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
May 11, 2026
Circle Internet Group (CRCL): What to Expect from the Q1 2026 Earnings Report

Circle Internet Group (CRCL): What to Expect from the Q1 2026 Earnings Report

Key Takeaways

  • Analysts expect Q1 2026 revenue of $717 million, reflecting continued expansion in stablecoin infrastructure.
  • Consensus EPS estimate stands at $0.15-$0.18 per share, down slightly from prior revisions.
  • USDC circulation growth and reserve income remain key focuses, building on Q4 2025's 77% revenue surge to $770 million.
  • Zacks Earnings ESP suggests potential for a beat, with historical average surprise of over 200%.
  • Regulatory tailwinds like stablecoin legislation could boost sentiment heading into the May 11 report.

Earnings Context and Why It Matters

As someone closely following the blockchain space, I see Circle Internet Group (CRCL), the issuer of USDC—the second-largest stablecoin—as a key player in payments and financial infrastructure. The upcoming Q1 2026 earnings report on May 11 feels particularly significant. It's the first full quarter of 2026 after a strong 2025, where revenue and reserve income reached $2.75 billion, up 64% year-over-year. From what I see, investors are focused on whether USDC adoption will hold steady amid the crypto market's recovery and new partnerships like those with Mesh and Kyriba. Shares have climbed nearly 50% year-to-date, though they've been volatile within a 52-week range of $49.90 to $298.99. These results could indicate if Circle can sustain its momentum against competitors like Tether while adapting to regulatory changes.

Earnings Expectations

Looking at the numbers, analysts project consensus revenue of $717.13 million for the quarter ended March 31, 2026. This growth stems from reserve income on USDC holdings and platform fees. The EPS consensus sits at $0.15 per share, with some estimates reaching $0.18—reflecting a modest downward revision over the past 60 days. This comes after Q4 2025's standout performance, where revenue jumped 77% year-over-year to $770.23 million and EPS came in at $0.43 against an expected $0.25.

One thing that stands out is USDC circulation, which drives reserve income through interest on reserves, along with expansion in Circle Mint for institutional clients. Circle has a strong track record, beating EPS estimates by an average of 219% over the last three quarters, often boosted by crypto rallies and partnerships. Post-earnings stock moves have been pronounced: +35.5% after Q4, though mixed in other periods. I'll be paying close attention to guidance on full-year 2026 growth and updates on the Arc blockchain.

Market Reaction and Investor Sentiment

Sentiment heading into this report strikes me as cautiously optimistic. CRCL shares recently traded at $113.67, up 0.37%, following a 5-7% weekly dip tied to broader market concerns. The positive Earnings ESP of +6.42% and Zacks Rank #3 point to a potential beat, though risks like USDC redemptions or regulatory hurdles linger. Implied volatility points to about an 11% one-day move after the report. Historically, beats have sparked rallies, but misses could hit harder given the stock's high beta and recent trading volumes exceeding 12 million shares.

Leveraging AI Tools in My Analysis

In reviewing CRCL ahead of earnings, I turned to Tickeron’s AI Screener, which I use regularly to filter stocks based on technical patterns, fundamentals, and AI signals. It scans thousands of stocks and ETFs with customizable criteria like industry, market cap, and performance metrics, helping spot opportunities like this one more efficiently than manual methods. I also checked this using Tickeron’s AI Daily Buy/Sell Signals to gauge short-term patterns. For traders like me, these tools streamline the process of identifying breakout candidates and trends—worth exploring if you're building your watchlist.

Forward Outlook and Key Factors to Monitor

After the earnings release, attention will turn to management's full-year 2026 guidance, which may highlight USDC growth targets—potentially around 40%, based on prior comments—and progress on the Circle Payments Network (CPN). In my view, catalysts like advancements in Arc, the enterprise blockchain dubbed an "Economic OS," and AI integrations for programmable money could drive further upside. Stablecoin legislation, such as the CLARITY Act, might accelerate institutional adoption, lifting circulation and reserve yields in a higher-rate environment.

That said, it's important to keep an eye on USDC reserve composition—cash and Treasuries—for liquidity risks during potential redemption spikes. Cost pressures from platform development and competition from Tether's USDT are ongoing concerns. I'll be watching demand indicators from partnerships and monthly attestations for signs of sustained momentum, alongside efforts to diversify revenue through non-reserve sources like minting fees.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CRCL

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


CRCL in upward trend: price may ascend as a result of having broken its lower Bollinger Band on September 16, 2026

CRCL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 8 of 9 cases where CRCL's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

CRCL moved above its 50-day moving average on October 05, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +3.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRCL advanced for three days, in 50 of 62 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

The Aroon Indicator entered an Uptrend today. In 21 of 34 cases where CRCL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.

Bearish Trend Analysis

The 10-day RSI Indicator for CRCL moved out of overbought territory on September 04, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 2 similar instances where the indicator moved out of overbought territory. In 2 of the 2 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRCL as a result. In 25 of 25 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for CRCL turned negative on September 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 6 similar instances when the indicator turned negative. In 5 of the 6 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRCL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 55 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. CRCL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.207) is normal, around the industry mean (4.351). P/E Ratio (17.194) is within average values for comparable stocks, (30.023). CRCL's Projected Growth (PEG Ratio) (4.345) is very high in comparison to the industry average of (0.809). Dividend Yield (0.000) settles around the average of (0.016) among similar stocks. P/S Ratio (6.954) is also within normal values, averaging (16.763).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

Notable companies

The most notable companies in this group are Morgan Stanley (NYSE:MS), Goldman Sachs Group (NYSE:GS), Charles Schwab Corp (The) (NYSE:SCHW), Gold.com Inc. (NYSE:GOLD).

Industry description

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

Market Cap

The average market capitalization across the Investment Banks/Brokers Industry is 12.69B. The market cap for tickers in the group ranges from 590 to 304.12B. MS holds the highest valuation in this group at 304.12B. The lowest valued company is FSSLD at 590.

High and low price notable news

The average weekly price growth across all stocks in the Investment Banks/Brokers Industry was -2%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was 3%. XP experienced the highest price growth at 39%, while PMAX experienced the biggest fall at -35%.

Volume

The average weekly volume growth across all stocks in the Investment Banks/Brokers Industry was 12%. For the same stocks of the Industry, the average monthly volume growth was -6% and the average quarterly volume growth was -50%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 66
P/E Growth Rating: 63
Price Growth Rating: 59
SMR Rating: 74
Profit Risk Rating: 86
Seasonality Score: 24 (-100 ... +100)
View a ticker or compare two or three
CRCL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry InvestmentBanksBrokers

Industry
N/A
Address
One World Trade Center
Phone
+1 332 334-0660
Employees
1100
Web
https://www.circle.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
GE Aerospace (GE) stock declined -12% over the past 30 days, falling from around $333 to $293, amid profit-taking after record highs near $348. Over the past quarter, the stock is down -8%, reflecting post-earnings selloff despite strong Q4 2025 results with 20% revenue growth.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
NBR stock rose approximately +12% over the last 30 days, driven by positive momentum in the oil and gas drilling sector and strong Q4 earnings beat. Over the past quarter, the stock surged +58%, fueled by robust YTD performance, debt reduction efforts, and improved operational results in international drilling.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.